Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
-
* Corresponding author: RuiRong Yuan yuanru@umdnj.edu
Journal of Hematology & Oncology 2009, 2:45 doi:10.1186/1756-8722-2-45
Accesses
- Last 30 days: 238 accesses
- Last 365 days: 3405 accesses
- All time: 9962 accesses
Cited by
BioMed Central: 3 citations
|
Sean Kirby, Anjali Satoskar, Sergey Brodsky, Amy Pope-Harman, David Nunley, Charles Hitchcock, Ronald Pelletier, Patrick Ross, Tibor Nadasdy, Konstantin Shilo Diagnostic Pathology 2012, 7:25 (14 March 2012) |
|
Dan Xu, Teresa M O, Archil Shartava, Taylor C Fowles, Jianchang Yang, Louis M Fink, David C Ward, Martin C Mihm, Milton Waner, Yupo Ma Journal of Hematology & Oncology 2011, 4:54 (22 December 2011) |
|
Chemotherapy in advanced bladder cancer: current status and future Nabil Ismaili, Mounia Amzerin, Aude Flechon Journal of Hematology & Oncology 2011, 4:35 (9 September 2011) |